Mason Archival Repository Service

Acriflavine as a Novel Venezuelan Equine Encephalitis Virus Therapeutic

Show simple item record

dc.contributor.advisor Kehn-Hall, Kylene
dc.contributor.author Hooper, Idris
dc.creator Hooper, Idris
dc.date 2013-05-02
dc.date.accessioned 2013-09-09T20:11:34Z
dc.date.available 2014-09-09T16:48:00Z
dc.date.issued 2013-09-09
dc.identifier.uri https://hdl.handle.net/1920/8435
dc.description.abstract Venezuelan equine encephalitis virus (VEEV) is a positive-sense ssRNA virus whose transmission has increased in Central and South America with cases being reported in the southern United States. VEEV can infect humans in addition to equines and can cause encephalitis in both. There are no current FDA licensed vaccines or specific therapies against VEEV so development of novel therapeutic compounds is necessary to combat this new threat. With this aim, our research focuses on the possible interactions of VEEV with host microRNA (miRNA) machinery and how this pathway could prove to be a useful therapeutic target. Studies have shown that some viruses, like Hepatitis C virus, use the miRNA pathway to enhance replication. These interactions were tested through VEEV infection of cells deficient in selected miRNA processing machinery. In this study, we wanted to test the effects of some RISC inhibitors on VEEV replication. One of these inhibitors, acriflavine (ACF), is a derivative of acridine that is used as an antiseptic, fungicide and in the past was used to treat sleeping sickness. Treatment of VEEV infected cells with ACF dramatically reduced viral titers and protein expression when compared to controls. Intracellular capsid RNA levels were also reduced in ACF treated cells. Differentiated neurons infected with VEEV also showed increased survival and had lower viral titers upon treatment with ACF. When tested on a murine model, ACF increased survival in C3H/HeN mice compared to the placebo. Combined, these results suggest miRNA genesis is necessary for productive VEEV infection, with the nuclear processing and RISC-binding steps being most significant and that ACF could serve as an effective therapeutic for VEEV infection.
dc.language.iso en en_US
dc.subject Acriflavine en_US
dc.subject VEEV en_US
dc.subject miRNA en_US
dc.subject therapeutic en_US
dc.subject Argonoute 2 en_US
dc.title Acriflavine as a Novel Venezuelan Equine Encephalitis Virus Therapeutic en_US
dc.type Thesis en
thesis.degree.name Master of Science in Biology en_US
thesis.degree.level Master's en
thesis.degree.discipline Biology en
thesis.degree.grantor George Mason University en


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search MARS


Browse

My Account

Statistics